Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis
Research on long-term survival after resection of giant (≥ 10 cm) and non-giant hepatocellular carcinoma (HCC) (< 10 cm) has produced conflicting results. This study aimed to investigate whether oncological outcomes and safety profiles of resection differ between giant and non-giant HCC. PubMed,...
Saved in:
Published in: | World journal of gastrointestinal surgery Vol. 15; no. 2; pp. 273 - 286 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Baishideng Publishing Group Inc
27-02-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Research on long-term survival after resection of giant (≥ 10 cm) and non-giant hepatocellular carcinoma (HCC) (< 10 cm) has produced conflicting results.
This study aimed to investigate whether oncological outcomes and safety profiles of resection differ between giant and non-giant HCC.
PubMed, MEDLINE, EMBASE, and Cochrane databases were searched. Studies designed to investigate the outcomes of giant
non-giant HCC were included. The primary endpoints were overall survival (OS) and disease-free survival (DFS). The secondary endpoints were postoperative complications and mortality rates. All studies were assessed for bias using the Newcastle-Ottawa Scale.
24 retrospective cohort studies involving 23747 patients (giant = 3326; non-giant = 20421) who underwent HCC resection were included. OS was reported in 24 studies, DFS in 17 studies, 30-d mortality rate in 18 studies, postoperative complications in 15 studies, and post-hepatectomy liver failure (PHLF) in six studies. The HR was significantly lower for non-giant HCC in both OS (HR 0.53, 95%CI: 0.50-0.55,
< 0.001) and DFS (HR 0.62, 95%CI: 0.58-0.84,
< 0.001). No significant difference was found for 30-d mortality rate (OR 0.73, 95%CI: 0.50-1.08,
= 0.116), postoperative complications (OR 0.81, 95%CI: 0.62-1.06,
= 0.140), and PHLF (OR 0.81, 95%CI: 0.62-1.06,
= 0.140).
Resection of giant HCC is associated with poorer long-term outcomes. The safety profile of resection was similar in both groups; however, this may have been confounded by reporting bias. HCC staging systems should account for the size differences. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Corresponding author: Aaron JL Lee, MBBS, Doctor, Lee Kong Chian School of Medicine, Nanyang Technological University, No. 11 Mandalay Rd, Singapore 308232, Singapore. alee047@e.ntu.edu.sg Author contributions: Lee AJ, Wu AG, Yew KC, Shelat VG confirm contribution to study conception and design; Lee AJ, Wu AG contributed to data collection; Lee AJ, Wu AG contributed to analysis and interpretation of results; Lee AJ, Wu AG, Yew KC, Shelat VG contributed to draft manuscript preparation; All authors reviewed the results and approved the final version of the manuscript |
ISSN: | 1948-9366 1948-9366 |
DOI: | 10.4240/wjgs.v15.i2.273 |